TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and oligonucleotide capabilities, unifying therapeutic design across all major ...
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc (ICAD). (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in ...
EXAONE 4.5 is a sophisticated Vision-Language Model (VLM) that integrates a proprietary vision encoder with a Large Language Model (LLM) into a unified architecture. This latest advancement builds on ...
We still live in a keyboard world, but every signal says we shouldn’t. Stanford researchers found that speech recognition can be about three times faster than ...
NORTHAMPTON, MA / ACCESS Newswire / April 2, 2026 / Key TakeawaysCombatting Home Modality Loss: To help address the 30% of patients who leave peritoneal dialysis (PD)- a home treatment option - within ...
insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ (Therapeutic Machine Learning) platform. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results